Calian Group (TSE:CGY – Free Report) had its price objective reduced by Ventum Financial from C$70.00 to C$68.00 in a report issued on Wednesday morning,BayStreet.CA reports.
A number of other analysts also recently issued reports on CGY. Cormark cut their price objective on Calian Group from C$74.00 to C$73.00 in a research report on Friday, August 9th. CIBC cut their price objective on Calian Group from C$76.00 to C$63.00 in a research report on Friday, August 9th. Finally, Royal Bank of Canada cut their price objective on Calian Group from C$75.00 to C$65.00 in a research report on Friday, August 9th. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of C$72.29.
Check Out Our Latest Stock Report on Calian Group
Calian Group Stock Down 0.9 %
Calian Group Company Profile
Calian Group Ltd. provides business services and solutions in Canada and internationally. It operates through four segment: Advanced Technologies, Health, Learning, and IT and Cyber Solutions (ITCS). The company offers systems engineering, software development, integration design, embedded design, operational management and lifecycle support, modelling and simulation-enabled design, and research & development solutions and services; environmental and radiation protection, decommissioning and waste management, regulatory affairs and licensing, and emergency preparedness and training services; and sophisticated communication systems for the satellite industry, such as antennas, RF systems, decimator RF spectrum analyzers, in-orbit test systems, software defined solutions, operations and teleport services, transmitters, receivers, and modems.
Recommended Stories
- Five stocks we like better than Calian Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Dow Jones Industrial Average (DJIA)?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.